TY - JOUR T1 - What Represents Treatment Efficacy in Long-term Studies of Gout Flare Prevention? An Interview Study of People With Gout JF - The Journal of Rheumatology JO - J Rheumatol DO - 10.3899/jrheum.210476 SP - jrheum.210476 AU - Jeremy Holyer AU - Andrea Garcia-Guillen AU - William J. Taylor AU - Angelo L. Gaffo AU - Merryn Gott AU - Julia Slark AU - Anne Horne AU - Isabel Su AU - Nicola Dalbeth AU - Sarah Stewart Y1 - 2021/09/01 UR - http://www.jrheum.org/content/early/2021/09/13/jrheum.210476.abstract N2 - Objective The patient experience of gout flares is multidimensional, with several contributing factors including pain intensity, duration, and frequency. There is currently no consistent method for reporting gout flare burden in long-term studies. This study aimed to determine which factors contribute to patient perceptions of treatment efficacy in long-term studies of gout flare prevention. Methods This study involved face-to-face interviews with people with gout using visual representations of gout flare patterns. Participants were shown different flare scenarios over a hypothetical 6-month treatment period that portrayed varying flare frequency, pain intensity, and flare duration. The participants were asked to indicate and discuss which scenario they believed was most indicative of successful treatment over time. Quantitative data relating to the proportion of participants selecting each scenario were reported using descriptive statistics. A qualitative descriptive approach was used to code and categorize the data from the interview transcripts. Results Twenty-two people with gout participated in the semistructured interviews. All 3 factors of pain intensity, flare duration, and flare frequency influenced participants' perception of treatment efficacy. However, a shorter flare duration was the most common indicator of successful treatment, with half of participants (n = 11, 50%) selecting the scenario with a shorter flare duration over those with less painful flares. Conclusion Flare duration, flare frequency, and pain severity are all taken into account by patients with gout when considering treatment efficacy over time. Long-term studies of gout should ideally capture all these factors to better represent patients' experience of treatment success. ER -